Listed

Medical Properties Trust Inc

MPTNYSECIK 1287865Real estateFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$252.1m, Q1 FY2026
Net income$32.8m, Q1 FY2026
Medical Properties Trust Inc, income statement, quarterly
Line itemUnitQ2 FY20232023-06-30Q3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31
Revenue$m337Revenue, Q2 FY2023, three months to 2023-06-30$337.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2024-08-09, accession 0000950170-24-094888.Report this figure307Revenue, Q3 FY2023, three months to 2023-09-30$306.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-12, accession 0000950170-24-125623.Report this figure(122)Revenue, Q4 FY2023, three months to 2023-12-31−$122.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-073587. Derived: 12-month figure less the 9-month figure.Report this figure271Revenue, Q1 FY2024, three months to 2024-03-31$271.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-09, accession 0000950170-25-068203.Report this figure267Revenue, Q2 FY2024, three months to 2024-06-30$266.6m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-08, accession 0000950170-25-106022.Report this figure226Revenue, Q3 FY2024, three months to 2024-09-30$225.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-07, accession 0001193125-25-272324.Report this figure232Revenue, Q4 FY2024, three months to 2024-12-31$231.8m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-073587. Derived: 12-month figure less the 9-month figure.Report this figure224Revenue, Q1 FY2025, three months to 2025-03-31$223.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure240Revenue, Q2 FY2025, three months to 2025-06-30$240.4m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-08, accession 0000950170-25-106022.Report this figure238Revenue, Q3 FY2025, three months to 2025-09-30$237.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-07, accession 0001193125-25-272324.Report this figure270Revenue, Q4 FY2025, three months to 2025-12-31$270.3m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-073587. Derived: 12-month figure less the 9-month figure.Report this figure252Revenue, Q1 FY2026, three months to 2026-03-31$252.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure
Cost of revenue$m(28.7)Cost of revenue, Q2 FY2023, three months to 2023-06-30−$28.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2023-08-09, accession 0000950170-23-040734. Derived: 6-month figure less the 3-month figure.Report this figure28.8Cost of revenue, Q3 FY2023, three months to 2023-09-30$28.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2023-11-09, accession 0000950170-23-062169. Derived: 9-month figure less the 6-month figure.Report this figure(72.1)Cost of revenue, Q4 FY2023, three months to 2023-12-31−$72.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2024-02-29, accession 0000950170-24-023248. Derived: 12-month figure less the 9-month figure.Report this figure40.9Cost of revenue, Q1 FY2024, three months to 2024-03-31$40.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-05-29, accession 0000950170-24-065929.Report this figure4.3Cost of revenue, Q2 FY2024, three months to 2024-06-30$4.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-08-09, accession 0000950170-24-094888. Derived: 6-month figure less the 3-month figure.Report this figure7.8Cost of revenue, Q3 FY2024, three months to 2024-09-30$7.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-12, accession 0000950170-24-125623. Derived: 9-month figure less the 6-month figure.Report this figure21.1Cost of revenue, Q4 FY2024, three months to 2024-12-31$21.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2025-03-03, accession 0000950170-25-030989. Derived: 12-month figure less the 9-month figure.Report this figure81.4Cost of revenue, Q1 FY2025, three months to 2025-03-31$81.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-09, accession 0000950170-25-068203.Report this figure19.8Cost of revenue, Q2 FY2025, three months to 2025-06-30$19.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-08, accession 0000950170-25-106022. Derived: 6-month figure less the 3-month figure.Report this figure(22.3)Cost of revenue, Q3 FY2025, three months to 2025-09-30−$22.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-07, accession 0001193125-25-272324. Derived: 9-month figure less the 6-month figure.Report this figure11.4Cost of revenue, Q4 FY2025, three months to 2025-12-31$11.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-26, accession 0001193125-26-073587. Derived: 12-month figure less the 9-month figure.Report this figure97.3Cost of revenue, Q1 FY2026, three months to 2026-03-31$97.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure
Operating income$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Interest expense$m104Interest expense, Q2 FY2023, three months to 2023-06-30$104.5m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-09, accession 0000950170-24-094888.Report this figure107Interest expense, Q3 FY2023, three months to 2023-09-30$106.7m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-12, accession 0000950170-24-125623.Report this figure102Interest expense, Q4 FY2023, three months to 2023-12-31$102.3m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-26, accession 0001193125-26-073587. Derived: 12-month figure less the 9-month figure.Report this figure109Interest expense, Q1 FY2024, three months to 2024-03-31$108.7m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-09, accession 0000950170-25-068203.Report this figure101Interest expense, Q2 FY2024, three months to 2024-06-30$101.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-08, accession 0000950170-25-106022.Report this figure106Interest expense, Q3 FY2024, three months to 2024-09-30$106.2m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-07, accession 0001193125-25-272324.Report this figure101Interest expense, Q4 FY2024, three months to 2024-12-31$101.5m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-26, accession 0001193125-26-073587. Derived: 12-month figure less the 9-month figure.Report this figure116Interest expense, Q1 FY2025, three months to 2025-03-31$115.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure130Interest expense, Q2 FY2025, three months to 2025-06-30$129.7m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-08, accession 0000950170-25-106022.Report this figure132Interest expense, Q3 FY2025, three months to 2025-09-30$132.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-07, accession 0001193125-25-272324.Report this figure132Interest expense, Q4 FY2025, three months to 2025-12-31$132.5m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-26, accession 0001193125-26-073587. Derived: 12-month figure less the 9-month figure.Report this figure133Interest expense, Q1 FY2026, three months to 2026-03-31$133.3m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure
Income tax$m(148)Income tax, Q2 FY2023, three months to 2023-06-30−$148.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-08-09, accession 0000950170-24-094888.Report this figure10.1Income tax, Q3 FY2023, three months to 2023-09-30$10.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0000950170-24-125623.Report this figure4.0Income tax, Q4 FY2023, three months to 2023-12-31$4.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001193125-26-073587. Derived: 12-month figure less the 9-month figure.Report this figure10.9Income tax, Q1 FY2024, three months to 2024-03-31$10.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-09, accession 0000950170-25-068203.Report this figure14.6Income tax, Q2 FY2024, three months to 2024-06-30$14.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-08, accession 0000950170-25-106022.Report this figure9.0Income tax, Q3 FY2024, three months to 2024-09-30$9.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-07, accession 0001193125-25-272324.Report this figure9.6Income tax, Q4 FY2024, three months to 2024-12-31$9.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001193125-26-073587. Derived: 12-month figure less the 9-month figure.Report this figure9.4Income tax, Q1 FY2025, three months to 2025-03-31$9.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure9.8Income tax, Q2 FY2025, three months to 2025-06-30$9.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-08, accession 0000950170-25-106022.Report this figure10.9Income tax, Q3 FY2025, three months to 2025-09-30$10.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-07, accession 0001193125-25-272324.Report this figure8.5Income tax, Q4 FY2025, three months to 2025-12-31$8.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-26, accession 0001193125-26-073587. Derived: 12-month figure less the 9-month figure.Report this figure(32.8)Income tax, Q1 FY2026, three months to 2026-03-31−$32.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure
Net income$m(42.0)Net income, Q2 FY2023, three months to 2023-06-30−$42.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-08-09, accession 0000950170-24-094888.Report this figure117Net income, Q3 FY2023, three months to 2023-09-30$116.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125623.Report this figure(664)Net income, Q4 FY2023, three months to 2023-12-31−$663.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-073587. Derived: 12-month figure less the 9-month figure.Report this figure(876)Net income, Q1 FY2024, three months to 2024-03-31−$875.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-09, accession 0000950170-25-068203.Report this figure(321)Net income, Q2 FY2024, three months to 2024-06-30−$320.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-08, accession 0000950170-25-106022.Report this figure(801)Net income, Q3 FY2024, three months to 2024-09-30−$801.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272324.Report this figure(413)Net income, Q4 FY2024, three months to 2024-12-31−$412.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-073587. Derived: 12-month figure less the 9-month figure.Report this figure(118)Net income, Q1 FY2025, three months to 2025-03-31−$118.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure(98.4)Net income, Q2 FY2025, three months to 2025-06-30−$98.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-08, accession 0000950170-25-106022.Report this figure(77.7)Net income, Q3 FY2025, three months to 2025-09-30−$77.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001193125-25-272324.Report this figure17.3Net income, Q4 FY2025, three months to 2025-12-31$17.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-073587. Derived: 12-month figure less the 9-month figure.Report this figure32.8Net income, Q1 FY2026, three months to 2026-03-31$32.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure
Diluted EPS$ per share(0.07)Diluted EPS, Q2 FY2023, three months to 2023-06-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-08-09, accession 0000950170-24-094888.Report this figure0.19Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0000950170-24-125623.Report this figurenot reported(1.46)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$1.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-09, accession 0000950170-25-068203.Report this figure(0.54)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.54 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-08, accession 0000950170-25-106022.Report this figure(1.34)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$1.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001193125-25-272324.Report this figurenot reported(0.20)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.20 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure(0.16)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-08, accession 0000950170-25-106022.Report this figure(0.13)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001193125-25-272324.Report this figurenot reported0.05Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure
Basic EPS$ per share(0.07)Basic EPS, Q2 FY2023, three months to 2023-06-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-08-09, accession 0000950170-24-094888.Report this figure0.19Basic EPS, Q3 FY2023, three months to 2023-09-30$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0000950170-24-125623.Report this figurenot reported(1.46)Basic EPS, Q1 FY2024, three months to 2024-03-31−$1.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-09, accession 0000950170-25-068203.Report this figure(0.54)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.54 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-08, accession 0000950170-25-106022.Report this figure(1.34)Basic EPS, Q3 FY2024, three months to 2024-09-30−$1.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-07, accession 0001193125-25-272324.Report this figurenot reported(0.20)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.20 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure(0.16)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-08, accession 0000950170-25-106022.Report this figure(0.13)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-07, accession 0001193125-25-272324.Report this figurenot reported0.05Basic EPS, Q1 FY2026, three months to 2026-03-31$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure

Balance sheet

Cash and equivalents$425.0m, Q1 FY2026
Long-term debt$9.66bn, Q1 FY2026
Shareholders' equity$4.54bn, Q1 FY2026
Medical Properties Trust Inc, balance sheet, quarterly
Line itemUnitQ2 FY20232023-06-30Q3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31
Cash and equivalents$bn0.3Cash and equivalents, Q2 FY2023, at 2023-06-30$324.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-09, accession 0000950170-24-094888.Report this figure0.3Cash and equivalents, Q3 FY2023, at 2023-09-30$340.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0000950170-24-125623.Report this figure0.3Cash and equivalents, FY2023, at 2023-12-31$250.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-26, accession 0001193125-26-073587.Report this figure0.2Cash and equivalents, Q1 FY2024, at 2024-03-31$224.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-09, accession 0000950170-25-068203.Report this figure0.6Cash and equivalents, Q2 FY2024, at 2024-06-30$606.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-08, accession 0000950170-25-106022.Report this figure0.3Cash and equivalents, Q3 FY2024, at 2024-09-30$275.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-07, accession 0001193125-25-272324.Report this figure0.3Cash and equivalents, FY2024, at 2024-12-31$332.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure0.7Cash and equivalents, Q1 FY2025, at 2025-03-31$673.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure0.5Cash and equivalents, Q2 FY2025, at 2025-06-30$509.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-08, accession 0000950170-25-106022.Report this figure0.4Cash and equivalents, Q3 FY2025, at 2025-09-30$396.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-07, accession 0001193125-25-272324.Report this figure0.5Cash and equivalents, FY2025, at 2025-12-31$540.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure0.4Cash and equivalents, Q1 FY2026, at 2026-03-31$425.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure
Total assets$bn19.2Total assets, Q2 FY2023, at 2023-06-30$19.20bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-08-09, accession 0000950170-23-040734.Report this figure19.0Total assets, Q3 FY2023, at 2023-09-30$19.00bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0000950170-23-062169.Report this figure18.3Total assets, FY2023, at 2023-12-31$18.30bn. XBRL concept us-gaap:Assets. 10-K filed 2025-03-03, accession 0000950170-25-030989.Report this figure17.3Total assets, Q1 FY2024, at 2024-03-31$17.30bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-29, accession 0000950170-24-065929.Report this figure16.2Total assets, Q2 FY2024, at 2024-06-30$16.19bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-09, accession 0000950170-24-094888.Report this figure15.2Total assets, Q3 FY2024, at 2024-09-30$15.24bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0000950170-24-125623.Report this figure14.3Total assets, FY2024, at 2024-12-31$14.29bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-26, accession 0001193125-26-073587.Report this figure14.9Total assets, Q1 FY2025, at 2025-03-31$14.85bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-09, accession 0000950170-25-068203.Report this figure15.2Total assets, Q2 FY2025, at 2025-06-30$15.15bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-08, accession 0000950170-25-106022.Report this figure14.9Total assets, Q3 FY2025, at 2025-09-30$14.92bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-07, accession 0001193125-25-272324.Report this figure15.0Total assets, FY2025, at 2025-12-31$15.00bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure14.8Total assets, Q1 FY2026, at 2026-03-31$14.76bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure
Total liabilities$bn10.9Total liabilities, Q2 FY2023, at 2023-06-30$10.89bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-08-09, accession 0000950170-23-040734.Report this figure10.7Total liabilities, Q3 FY2023, at 2023-09-30$10.72bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0000950170-23-062169.Report this figure10.7Total liabilities, FY2023, at 2023-12-31$10.67bn. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-03, accession 0000950170-25-030989.Report this figure10.6Total liabilities, Q1 FY2024, at 2024-03-31$10.60bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-29, accession 0000950170-24-065929.Report this figure10.0Total liabilities, Q2 FY2024, at 2024-06-30$10.00bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-09, accession 0000950170-24-094888.Report this figure9.8Total liabilities, Q3 FY2024, at 2024-09-30$9.80bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0000950170-24-125623.Report this figure9.5Total liabilities, FY2024, at 2024-12-31$9.46bn. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-26, accession 0001193125-26-073587.Report this figure10.1Total liabilities, Q1 FY2025, at 2025-03-31$10.09bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-09, accession 0000950170-25-068203.Report this figure10.3Total liabilities, Q2 FY2025, at 2025-06-30$10.32bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-08, accession 0000950170-25-106022.Report this figure10.3Total liabilities, Q3 FY2025, at 2025-09-30$10.26bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-07, accession 0001193125-25-272324.Report this figure10.4Total liabilities, FY2025, at 2025-12-31$10.39bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure10.2Total liabilities, Q1 FY2026, at 2026-03-31$10.22bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure
Long-term debt$bn10.2Long-term debt, Q2 FY2023, at 2023-06-30$10.24bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2023-08-09, accession 0000950170-23-040734.Report this figure10.2Long-term debt, Q3 FY2023, at 2023-09-30$10.16bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2023-11-09, accession 0000950170-23-062169.Report this figure10.1Long-term debt, FY2023, at 2023-12-31$10.06bn. XBRL concept us-gaap:LongTermDebt. 10-K filed 2025-03-03, accession 0000950170-25-030989.Report this figure10.1Long-term debt, Q1 FY2024, at 2024-03-31$10.10bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-05-29, accession 0000950170-24-065929.Report this figure9.4Long-term debt, Q2 FY2024, at 2024-06-30$9.37bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-08-09, accession 0000950170-24-094888.Report this figure9.2Long-term debt, Q3 FY2024, at 2024-09-30$9.22bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2024-11-12, accession 0000950170-24-125623.Report this figure8.8Long-term debt, FY2024, at 2024-12-31$8.85bn. XBRL concept us-gaap:LongTermDebt. 10-K filed 2026-02-26, accession 0001193125-26-073587.Report this figure9.5Long-term debt, Q1 FY2025, at 2025-03-31$9.47bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-05-09, accession 0000950170-25-068203.Report this figure9.6Long-term debt, Q2 FY2025, at 2025-06-30$9.65bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-08-08, accession 0000950170-25-106022.Report this figure9.6Long-term debt, Q3 FY2025, at 2025-09-30$9.62bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-11-07, accession 0001193125-25-272324.Report this figure9.7Long-term debt, FY2025, at 2025-12-31$9.70bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure9.7Long-term debt, Q1 FY2026, at 2026-03-31$9.66bn. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure
Shareholders' equity$bn8.3Shareholders' equity, Q2 FY2023, at 2023-06-30$8.31bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-08-09, accession 0000950170-23-040734.Report this figure8.3Shareholders' equity, Q3 FY2023, at 2023-09-30$8.28bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2023-11-09, accession 0000950170-23-062169.Report this figure7.6Shareholders' equity, FY2023, at 2023-12-31$7.63bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-03-03, accession 0000950170-25-030989.Report this figure6.7Shareholders' equity, Q1 FY2024, at 2024-03-31$6.70bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-05-29, accession 0000950170-24-065929.Report this figure6.2Shareholders' equity, Q2 FY2024, at 2024-06-30$6.19bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-08-09, accession 0000950170-24-094888.Report this figure5.4Shareholders' equity, Q3 FY2024, at 2024-09-30$5.44bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0000950170-24-125623.Report this figure4.8Shareholders' equity, FY2024, at 2024-12-31$4.83bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-26, accession 0001193125-26-073587.Report this figure4.8Shareholders' equity, Q1 FY2025, at 2025-03-31$4.76bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-09, accession 0000950170-25-068203.Report this figure4.8Shareholders' equity, Q2 FY2025, at 2025-06-30$4.83bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-08, accession 0000950170-25-106022.Report this figure4.7Shareholders' equity, Q3 FY2025, at 2025-09-30$4.66bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001193125-25-272324.Report this figure4.6Shareholders' equity, FY2025, at 2025-12-31$4.61bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure4.5Shareholders' equity, Q1 FY2026, at 2026-03-31$4.54bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure

Cash flow

Operating cash flow−$14.3m, Q1 FY2026
Medical Properties Trust Inc, cash flow, quarterly
Line itemUnitQ2 FY20232023-06-30Q3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31
Operating cash flow$m76.5Operating cash flow, Q2 FY2023, three months to 2023-06-30$76.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-08-09, accession 0000950170-24-094888. Derived: 6-month figure less the 3-month figure.Report this figure158Operating cash flow, Q3 FY2023, three months to 2023-09-30$158.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0000950170-24-125623. Derived: 9-month figure less the 6-month figure.Report this figure135Operating cash flow, Q4 FY2023, three months to 2023-12-31$135.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-073587. Derived: 12-month figure less the 9-month figure.Report this figure74.3Operating cash flow, Q1 FY2024, three months to 2024-03-31$74.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-09, accession 0000950170-25-068203.Report this figure35.3Operating cash flow, Q2 FY2024, three months to 2024-06-30$35.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-08, accession 0000950170-25-106022. Derived: 6-month figure less the 3-month figure.Report this figure59.2Operating cash flow, Q3 FY2024, three months to 2024-09-30$59.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001193125-25-272324. Derived: 9-month figure less the 6-month figure.Report this figure76.7Operating cash flow, Q4 FY2024, three months to 2024-12-31$76.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-073587. Derived: 12-month figure less the 9-month figure.Report this figure0.4Operating cash flow, Q1 FY2025, three months to 2025-03-31$384.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure51.7Operating cash flow, Q2 FY2025, three months to 2025-06-30$51.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-08, accession 0000950170-25-106022. Derived: 6-month figure less the 3-month figure.Report this figure18.6Operating cash flow, Q3 FY2025, three months to 2025-09-30$18.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001193125-25-272324. Derived: 9-month figure less the 6-month figure.Report this figure160Operating cash flow, Q4 FY2025, three months to 2025-12-31$160.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-073587. Derived: 12-month figure less the 9-month figure.Report this figure(14.3)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$14.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure

Shares

Diluted shares (weighted)597.72m, Q1 FY2026
Medical Properties Trust Inc, shares, quarterly
Line itemUnitQ2 FY20222022-06-30Q3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31
Diluted shares (weighted)m shares599Diluted shares (weighted), Q2 FY2022, three months to 2022-06-30599,026,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-08-09, accession 0000950170-23-040734.Report this figure599Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30599,339,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0000950170-23-062169.Report this figure598Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31598,310,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-29, accession 0000950170-24-065929.Report this figure598Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30598,344,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-09, accession 0000950170-24-094888.Report this figure599Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30598,553,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0000950170-24-125623.Report this figure600Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31600,304,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-09, accession 0000950170-25-068203.Report this figure600Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30600,057,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-08, accession 0000950170-25-106022.Report this figure600Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30600,229,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-07, accession 0001193125-25-272324.Report this figure601Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31600,594,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure601Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30600,814,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-08, accession 0000950170-25-106022.Report this figure601Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30601,136,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-07, accession 0001193125-25-272324.Report this figure598Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31597,715,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure

Shares outstanding: 598.10mShares outstanding, period not labelled, at 2026-05-06598,100,000 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-05-08, accession 0001193125-26-214700.Report this figure at May 6, 2026, from the cover of the 10-Q filed May 8, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. Listed shows no prices and gives no investment advice.